267 filings
Page 4 of 14
424B3
tpbqi9ulm0ppjxiq
28 Apr 23
Prospectus supplement
4:02pm
EFFECT
kfn5n57syzl30
27 Apr 23
Notice of effectiveness
12:15am
CORRESP
7hkqd j9di0p
26 Apr 23
Correspondence with SEC
12:00am
CORRESP
ranxe oc97xq
26 Apr 23
Correspondence with SEC
12:00am
CORRESP
f2hfnq62
26 Apr 23
Correspondence with SEC
12:00am
8-K
xlig55 cpdg61d
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
UPLOAD
qcs6k
13 Apr 23
Letter from SEC
12:00am
8-K/A
ivwapvpbjxvttfsb
4 Apr 23
Entry into a Material Definitive Agreement
4:09pm
8-K
boa7p
31 Mar 23
Entry into a Material Definitive Agreement
4:50pm
8-K
elbtd8az9y
27 Mar 23
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
4:05pm
8-K
c5qe9ik5wg5tu3w
13 Mar 23
Regulation FD Disclosure
7:31am
8-K
58iwj4ll
3 Mar 23
Other Events
8:00am
S-8
w86f9q7lhwhjjqn0zy4
23 Feb 23
Registration of securities for employees
8:49am
8-K
fo56q6nks31 pwr251o
23 Feb 23
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
8:10am
8-K
1jfwmoln
24 Jan 23
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II
4:30pm
8-K
jtkcp3rfnxalhpzkt2zl
9 Jan 23
Other Events
8:14am
8-K
4jxs k7739ksvz4e
30 Dec 22
Other Events
4:05pm